Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jae-Joon Yim

Showing results (251-260 of 288) with videos related to

Pageof 29
Sort By:
Respirology (Carlton, Vic.)|March 28, 2012
Vitamin D deficiency and changes in serum vitamin D levels with treatment among tuberculosis patients in South KoreaHyeon-Kyoung Koo, Ji Sun Lee, Yun Jeong Jeong, et al.
Respirology (Carlton, Vic.)|July 5, 2012
Poor correlation between tuberculin skin tests and interferon-γ assays in close contacts of patients with multidrug-resistant tuberculosisKyung-Wook Jo, Kyeongman Jeon, Young Ae Kang, et al.
The Journal of Infection|March 11, 2014
Prognostic factors of Pneumocystis jirovecii pneumonia in patients without HIV infectionSoo Jung Kim, Jinwoo Lee, Young-Jae Cho, et al.
Annals of the American Thoracic Society|December 16, 2020
Amikacin Liposome Inhalation Suspension for <i>Mycobacterium avium</i> Complex Lung Disease: A 12-Month Open-Label Extension Clinical TrialKevin L Winthrop, Patrick A Flume, Rachel Thomson, et al.
Trials|August 17, 2022
Treatment shortening of drug-sensitive pulmonary tuberculosis using high-dose rifampicin for 3 months after culture conversion (Hi-DoRi-3): a study protocol for an open-label randomized clinical trialNakwon Kwak, Doosoo Jeon, Youngmok Park, et al.
Scientific Reports|April 30, 2026
Impact of vitamin D deficiency on 6-month culture conversion in nontuberculous mycobacterial pulmonary diseaseTae-Ok Kim, Nakwon Kwak, Doosoo Jeon, et al.
American Journal of Respiratory and Critical Care Medicine|September 12, 2025
Novel Genetic Loci for Nontuberculous Mycobacterial Pulmonary Disease and Potential Protective Effect of Body Mass IndexKyungtaek Park, Hyejin Kim, Hee Jae Huh, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 2, 2024
Improvement in Health-Related Quality of Life Following Antibiotic Treatment in Nontuberculous Mycobacterial Pulmonary Disease: Initial Analysis of the NTM-KOREA CohortNakwon Kwak, Emily Henkle, Hyeontaek Hwang, et al.
Pulmonology|February 24, 2026
Management of nontuberculous mycobacterial Pulmonary disease refractory to guideline-based therapy: A systematic reviewDiana Moreira-Sousa, Beatriz Martins, Ana Aguiar, et al.
The European Respiratory Journal|November 6, 2025
Consensus on the management of refractory nontuberculous mycobacterial pulmonary diseaseDiana Moreira-Sousa, Beatriz Martins, Ana Aguiar, et al.
Pageof 29

Showing results (251-260 of 288) with videos related to

Sort By:
Pageof 29
Respirology (Carlton, Vic.)|March 28, 2012
Vitamin D deficiency and changes in serum vitamin D levels with treatment among tuberculosis patients in South KoreaHyeon-Kyoung Koo, Ji Sun Lee, Yun Jeong Jeong, et al.
Respirology (Carlton, Vic.)|July 5, 2012
Poor correlation between tuberculin skin tests and interferon-γ assays in close contacts of patients with multidrug-resistant tuberculosisKyung-Wook Jo, Kyeongman Jeon, Young Ae Kang, et al.
The Journal of Infection|March 11, 2014
Prognostic factors of Pneumocystis jirovecii pneumonia in patients without HIV infectionSoo Jung Kim, Jinwoo Lee, Young-Jae Cho, et al.
Annals of the American Thoracic Society|December 16, 2020
Amikacin Liposome Inhalation Suspension for <i>Mycobacterium avium</i> Complex Lung Disease: A 12-Month Open-Label Extension Clinical TrialKevin L Winthrop, Patrick A Flume, Rachel Thomson, et al.
Trials|August 17, 2022
Treatment shortening of drug-sensitive pulmonary tuberculosis using high-dose rifampicin for 3 months after culture conversion (Hi-DoRi-3): a study protocol for an open-label randomized clinical trialNakwon Kwak, Doosoo Jeon, Youngmok Park, et al.
Scientific Reports|April 30, 2026
Impact of vitamin D deficiency on 6-month culture conversion in nontuberculous mycobacterial pulmonary diseaseTae-Ok Kim, Nakwon Kwak, Doosoo Jeon, et al.
American Journal of Respiratory and Critical Care Medicine|September 12, 2025
Novel Genetic Loci for Nontuberculous Mycobacterial Pulmonary Disease and Potential Protective Effect of Body Mass IndexKyungtaek Park, Hyejin Kim, Hee Jae Huh, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 2, 2024
Improvement in Health-Related Quality of Life Following Antibiotic Treatment in Nontuberculous Mycobacterial Pulmonary Disease: Initial Analysis of the NTM-KOREA CohortNakwon Kwak, Emily Henkle, Hyeontaek Hwang, et al.
Pulmonology|February 24, 2026
Management of nontuberculous mycobacterial Pulmonary disease refractory to guideline-based therapy: A systematic reviewDiana Moreira-Sousa, Beatriz Martins, Ana Aguiar, et al.
The European Respiratory Journal|November 6, 2025
Consensus on the management of refractory nontuberculous mycobacterial pulmonary diseaseDiana Moreira-Sousa, Beatriz Martins, Ana Aguiar, et al.
Pageof 29